Predictive oncology stock.
Assess the Predictive Oncology stock price estimates. View analyst opinion as to whether the stock is a strong buy, strong sell or hold, based on analyst 12-Month POAI price targets.
Predictive Oncology Inc. (POAI) · Company Description · Contact Details · Stock Details · Key Executives · Latest SEC Filings ...Nov 24, 2023 · Stock analysis for Predictive Oncology Inc (POAI:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Nov 13, 2023 · Get Predictive Oncology Inc (POAI.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments EAGAN, Minn., March 16, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series F Preferred Stock, par value $0.01 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 p ...
The upgrade of Predictive Oncology Inc. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ...
Predictive Oncology stock price prediction is an act of determining the future value of Predictive Oncology shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Predictive Oncology's future price could yield a significant profit.
The estimated Net Worth of Carl I. Schwartz is at least 4.75 百万$ dollars as of 22 October 2020. Dr Schwartz owns over 640 units of Predictive Oncology stock worth over 4,318,394$ and over the last 7 years he sold POAI stock worth over 544$. In addition, he makes 433,000$ as CEO & Director at Predictive Oncology.The Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ...Here are three artificial intelligence stocks that could be acquired. SoundHound ( AI ): The company is exposed to a $500 million a year opportunity with autos and restaurants. Predictive Oncology ...Daniel Handley POAI stock SEC Form 4 insiders trading. Daniel has made over 4 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 6,000 units of POAI stock worth $2,460 on 15 December 20226,000 units of POAI stock worth $2,460 on 15 December 2022Discover historical prices for POAI stock on Yahoo Finance. View daily, weekly or monthly format back to when Predictive Oncology Inc. stock was issued.
The estimated Net Worth of Robert L Myers is at least $351 ezer dollars as of 2 December 2022. Mr Myers owns over 8,795 units of Predictive Oncology stock worth over $23,211 and over the last 6 years he sold POAI stock worth over $0. In addition, he makes $327,838 as CFO & Sec. at Predictive Oncology.
finance.yahoo.com - March 21 at 3:52 PM. Predictive Oncology Inc.: Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common Stock. finanznachrichten.de - March 17 at 10:22 AM. Predictive Oncology and Cancer Research Horizons partner up to pursue development of cancer drugs.
Find the latest historical data for Predictive Oncology Inc. Common Stock (POAI) at Nasdaq.com.Get a real-time Predictive Oncology Inc. (POAI) stock price quote with breaking news, financials, statistics, charts and more.News. Get the latest Predictive Oncology Inc. (POAI) stock news and headlines to help you in your trading and investing decisions.Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …Predictive Oncology (NASDAQ:POAI) Stock Price Passes Below Two Hundred Day Moving Average of $3.98. Predictive Oncology GAAP EPS of -$0.78, revenue of …EAGAN, Minn., March 16, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series F Preferred Stock, par value $0.01 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 p ...PITTSBURGH, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announced today that it has completed a multi-year study with UPMC Magee-Womens Hospital. The objective of the study was to evaluate the use of AI to build multi-omic machine learning (ML) models …
Nov 30, 2023 · Predictive Oncology Stock Forecast and Price Target. The average price target for Predictive Oncology's stock lately set by several renowned analysts is $3.29, which would result in a potential upside of approximately 6.47% if it reaches this mark by December 31, 2023. This estimation is based on a high estimate of $3.69 and a low estimate of ... Aug 10, 2023 · Predictive Oncology recorded revenue of $490,110 in the second quarter of 2023, compared to $371,591 in 2022. Sales of Streamway related products and services by our Eagan operating segment were ... He oversees Predictive Oncology’s solubility and stability contracts for numerous pharmaceutical/biotech companies. From 1981 to 2016, Dr. DeLucas was a faculty member at the University of Alabama at Birmingham (UAB) where he served as a Professor in the School of Optometry, Senior Scientist and Director of the Comprehensive Cancer Center X ...Predictive Oncology recorded revenue of $490,110 in the second quarter of 2023, compared to $371,591 in 2022. Sales of Streamway related products and services by our Eagan operating segment were ...Here are three artificial intelligence stocks that could be acquired. SoundHound ( AI ): The company is exposed to a $500 million a year opportunity with autos and restaurants. Predictive Oncology ...
1. Amgen (AMGN) Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. Amgen stock opened the day at $265.12 after a previous close of $264.59.Predictive Oncology Inc. (NASDAQ: POAI) Stock Price as of July 16: $1.15 Number of Hedge Fund Holders: 2. Predictive Oncology Inc. (NASDAQ: POAI) ranks 10th on the list of 10 best one dollar ...
According to CBS News, Harry Dent’s predictions in his books have never been right. His most accurate prediction was from his 1993 book; he predicted that the stock market would rise substantially, but he was a year early with his predictio...Welcome to Predictive Oncology The leading edge of a new frontier in drug discovery Integrating scientific rigor with machine learning • Overcoming challenges of clinical trials • Improving the probability of success • Collaborating with partners in biopharma • Advancing molecules to medicine with confidence and accuracy Connect with us Changing the game in drug … Home Read More »Predictive Oncology (NASDAQ:POAI) Stock Price Passes Below Two Hundred Day Moving Average of $3.98. Predictive Oncology GAAP EPS of -$0.78, revenue of …predictive oncology inc. certificate of designation of preferences, rights and limitations of. series e convertible preferred stock pursuant to section 151 of the. delaware general corporation law . effective june 13, 2019 .Predictive Oncology : If you can look past a reverse stock split, POAI stock is one worth watching. Rekor Systems ( REKR ): The company has a first-mover advantage in a sector that has the ...Clovis Oncology (NASDAQ:CLVS) issued its quarterly earnings data on Wednesday, November, 3rd. The biopharmaceutical company reported ($0.56) earnings per share for the quarter, missing analysts' consensus estimates of ($0.48) by $0.08. The biopharmaceutical company had revenue of $37.92 million for the quarter, compared to …Amesite Inc. (NASDAQ:AMST) posted its earnings results on Monday, November, 13th. The company reported ($0.35) EPS for the quarter. The company earned $0.06 million during the quarter. Amesite had a negative trailing twelve-month return on equity of 52.99% and a negative net margin of 552.07%.COMMON STOCK PURCHASE WARRANT . PREDICTIVE ONCOLOGY INC. Warrant Shares: _____ Initial Exercise Date: February 22, 2021 . ... 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Predictive Oncology Inc., a Delaware corporation ...
This article will tell you the best AI stocks under $1 to buy right now! ... Predictive Oncology is a Minnesota-based data and AI-driven discovery services company providing predictive models of tumor drug response. One of the subsidiaries of Predictive Oncology, TumorGenesis, utilizes specific and highly differentiated methods to grow …
Race Oncology Ltd () Stock Market info Recommendations: Buy or sell Race Oncology stock? Sydney Stock Market & Finance report, prediction for the future: You'll find the Race Oncology share forecasts, stock quote and buy / sell signals below.According to present data Race Oncology's RAC shares and potentially its market environment have …
Cardiff Oncology is a prime takeover target heading into 2022. The pharmaceutical industry appears poised for a record-breaking level of merger and acquisition (M&A) activity in 2022. Four ...Mar 22, 2023 · Effective March 16, 2023, Predictive Oncology and Cancer Research Horizons, the world’s largest private funder of cancer research, have partnered to drive the development of oncology drugs utilizing Predictive Oncology’s PEDAL platform that pairs artificial intelligence (AI) with the world’s largest biobank of tumor samples; Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …In 2023 so far, the iShares Biotechnology ETF (IBB) is down 7.5% while the S&P 500 is up more than 14%—but from 2012 to 2015, IBB beat the S&P 500 by more than 3-to-1. Picking the right biotech ...The Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ...EAGAN, Minn., April 04, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and ...A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its annual earnings. ... Predictive Oncology Inc. (POAI) Upgraded to Buy: What Does It Mean for the Stock?Dec 22, 2021 · The upgrade of Predictive Oncology Inc. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ...
Aug 10, 2023 · Predictive Oncology recorded revenue of $490,110 in the second quarter of 2023, compared to $371,591 in 2022. Sales of Streamway related products and services by our Eagan operating segment were ... Nov 30, 2023 · Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the ... Track Predictive Oncology Inc (POAI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsThe shares of common stock described above (but not the warrants or the shares of common stock underlying the warrants) were offered by the Company in the registered direct offerings pursuant to ...Instagram:https://instagram. top 10 stocks buy right nowarms stockge leadershipoprah winfrey ww Third, all of these shares are below a certain price of $ 3. As a result, they are relatively inexpensive, although the definition of penny stocks has changed over time. It basically includes all stocks traded for less than $ 5, although there are no hard and fast rules to talk about. They are here: ObsEva (NASDAQ: OBSV) Predictive oncology ...The latest price target for Predictive Oncology ( NASDAQ: POAI) was reported by HC Wainwright & Co. on Wednesday, June 30, 2021. The analyst firm set a price target for 5.00 expecting POAI to rise ... jetty insurance companydemo trading platforms Predictive Oncology, Pittsburgh, Pennsylvania. 294 likes. Predictive Oncology (NASDAQ:POAI) Changing the landscape of oncology drug discovery & enabling the deOverview Press Releases Events & Presentations Financials & Filings Stock Quote & Chart Corporate Governance Contact Us Stock Quote (POAI) NASDAQ CM: POAI $3.17 Oct 2, 2023 4:00 PM EDT Change 0 (0.00%) Volume 0 Today's Open -- Previous Close $3.17 Today's High $3.20 Today's Low $3.07 52 Week High $13.88 52 Week Low $2.47 Stock Chart best nurse liability insurance Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …Predictive Oncology Inc. Weekly Stock List Management's ability to "raise guidance" can often be a catalyst for market-beating returns in the quarters ahead. The third-quarter earnings season is ...Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...